BRIEF published on 07/15/2026 at 10:05, 3 months 16 days ago Darwin AG Rebrands to Novogenia AG to Enhance Global Presence Rebranding Strategic Focus Healthcare Market Corporate Identity Genetic Analysis
PRESS RELEASE published on 07/15/2026 at 10:00, 3 months 16 days ago Darwin AG becomes Novogenia AG, strengthening its international position Darwin AG rebrands as Novogenia AG to enhance international position following resolution at the Annual General Meeting, maintaining core focus on personalized healthcare products and genetic analysis Rebranding Genetic Analysis Darwin AG Novogenia AG Personalized Healthcare
BRIEF published on 06/26/2026 at 17:05, 4 months 5 days ago Résultats de l'assemblée générale annuelle 2026 de Darwin AG Stratégie D'entreprise Dividende Assemblée Générale Annuelle Approbation Des Actionnaires Changement De Nom D'entreprise
BRIEF published on 06/26/2026 at 17:05, 4 months 5 days ago Darwin AG's 2026 Annual General Meeting Outcomes Annual General Meeting Shareholder Approval Dividend Corporate Strategy Company Renaming
PRESS RELEASE published on 06/26/2026 at 17:00, 4 months 5 days ago Darwin AG Announces Results of the 2026 Annual General Meeting Darwin AG announces results of the 2026 Annual General Meeting, including approval of resolutions, dividend distribution, and change of name to Novogenia AG Dividend Distribution Resolutions Darwin AG 2026 Annual General Meeting Novogenia AG
BRIEF published on 05/12/2026 at 09:05, 5 months 19 days ago Darwin AG annonce un doublement de ses revenus en 2025 Croissance Des Revenus Investissements Informatiques Tests Génétiques Résultats Financiers 2025 Darwin AG
BRIEF published on 05/12/2026 at 09:05, 5 months 19 days ago Darwin AG Reports Doubling of Revenue in 2025 Revenue Growth Genetic Testing IT Investments 2025 Financial Results Darwin AG
PRESS RELEASE published on 05/12/2026 at 09:00, 5 months 19 days ago Darwin AG publishes financial figures and provides business update for 2025 Darwin AG publishes financial figures with positive net income for 2025, marking a transition to profitable growth. The company emphasizes international expansion and innovation Profitable Growth Financial Figures International Expansion Positive Net Income Darwin AG
BRIEF published on 04/09/2026 at 10:05, 6 months 22 days ago Darwin AG participera à des conférences financières clés en 2026 Résultats Financiers Investissement Dans Le Secteur De La Santé Darwin AG Investir 2026 Forum Des Actions
BRIEF published on 04/09/2026 at 10:05, 6 months 22 days ago Darwin AG to Attend Key Financial Conferences in 2026 Financial Results Healthcare Investment Equity Forum Darwin AG Invest 2026
Published on 10/30/2026 at 23:35, 21 hours 48 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 21 hours 53 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 2 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 5 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 4 hours 47 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 22 hours 34 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 22 hours 23 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 22 hours 23 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
